Healthcare Interoperability Solutions Market

Healthcare Interoperability Solutions Market by Type (EHR Interoperability, Health Information Exchange, Enterprise), Interoperability Levels (Foundational, Structural, Semantic), End User (Hospitals, Pharmacies, Clinics, Payers) - Global Forecast to 2026

Report Code: HIT 6989 Jan, 2022, by marketsandmarkets.com

[234 Pages Report] The global healthcare interoperability solutions market is projected to reach USD 5.7 billion by 2026 from USD 2.9 billion in 2021, at a CAGR of 13.9% during the forecast period. Growth in this market is driven by the growing need to curtail healthcare costs, government initiatives to enhance patient care & safety, government funding for healthcare interoperability, and the rapid adoption of EHR & other healthcare IT solutions. However, the lack of true interoperability solutions, lack of standards, and the use of outdated legacy systems are some factors restraining the growth of the healthcare interoperability solutions market to a certain extent during the forecast period.

Healthcare Interoperability Solutions Market

To know about the assumptions considered for the study, Request for Free Sample Report

COVID-19 Impact on the Healthcare interoperability solutions Market

The healthcare interoperability solutions market has been positively impacted by the pandemic, and this trend is expected to continue for the next few months. Interoperability and ineffective data management were challenges for healthcare organizations pre-COVID and were magnified further during the pandemic. Interoperability struggles led to clinicians missing important COVID-19 information, patient treatment delays, and the inability of clinicians to adequately document patients’ status. Data exchange was not only ineffective but often became impossible to coordinate due to the rapid changes each day of the pandemic. With new variants of the coronavirus igniting new surges of COVID-19 around the world, data sharing through interoperability grows even more urgent. From understanding any single patient’s complete medical journey to analyzing aggregated data at the community level, frontline providers and researchers need access to the most complete data sets available to track the disease, understand which protocols are most effective, and get ahead of the virus.

On the population level, interoperability has incalculable benefits for measuring vaccine efficacy. When data can be shared at the macro level, scientists can study the impact of vaccines on different populations and the implications of distribution inequities in traditionally underserved populations. Interoperability will allow us to understand and shed light on the effectiveness of the medicines we develop and the healthcare system’s ability to deliver these medicines to the people who need them. Public health depends on the data that interoperability can provide.

Healthcare interoperability solutions Market Dynamics

Drivers: Growing need to curtail healthcare costs

Healthcare costs have almost doubled over the last decade, especially in the US. The Organisation for Economic Co-operation and Development (OECD) anticipated increasing public expenditures on healthcare and long-term care in OECD countries from 6% of the GDP in 2018 to almost 9% by 2030 and 14% by 2060. Factors such as increasing health insurance premiums, the rising demand for quality healthcare services, the growing geriatric population, and the growing incidence of chronic disorders across the globe are responsible for the significant rise in healthcare costs. Another major factor contributing to this trend is the high dependency on traditional and technologically outdated clinical devices that increase the rate of readmission of patients and the chances of medical errors as well as increase the administration costs.

Restraints: Lack of standards

Lack of standards for sending, receiving, and managing information between EHR systems is one of the key restraints for the adoption of interoperability solutions. Mismatched types, strange data fields, and proprietary formats mean that data has to be manipulated and sanitized before it can be imported into another system. This lack of a common standard for capturing, transmitting, receiving, storing, and managing patient data causes delays and inaccuracies. Also, understanding and interpreting medical terminologies correctly is a bigger challenge. A completely interoperable system requires different levels of integration (inter as well as intra organization) and is difficult to obtain. Also, the healthcare industry mainly involves highly sensitive data in terms of required security. Hence, a dynamic and robust technique or approach must be appropriately selected for permitting secured sharing of sensitive health data in disparate interoperable healthcare domains.

Opportunities: Emerging markets for healthcare interoperability solutions in developing markets

In most of these emerging countries, interoperability solutions in the healthcare market are still in the early stages owing to factors such as lack of awareness, minimum availability of interoperable solutions, lack of IT infrastructure, and financial and social constraints. The growing population in these countries is also expected to increase the healthcare data volume in respective healthcare systems. This represents a significant growth opportunity for players operating in the market. Government initiatives for implementing interoperable solutions, a rise in government spending on healthcare systems, and the increasing adoption of automation technology are the major factors favoring the adoption of healthcare interoperability solutions in the emerging markets across the Asia Pacific.

Challenges: Shortage of healthcare IT professionals

The shortage of qualified resources is a major barrier to implementing interoperability solutions in hospitals. Currently, the demand for healthcare IT professionals far exceeds their supply, not just in developing markets but also in major markets such as the US and Europe. According to a report by the US Bureau of Labor Statistics, hospitals and physician practices in the US needed an additional 35,000 healthcare IT workers as of 2018. The bureau stated that an additional 41,000 professionals would be required in the healthcare information management (HIM) field by 2022 in the US. There is also a shortage of IT specialists in healthcare systems across Canada; ~79% of the current clinical IT workers need additional training. The growing number of healthcare IT initiatives further adds to the overall burden.

“Services was the largest and fastest-growing segment in the type of healthcare interoperability solutions market in 2020”

On the basis of type, the services segment accounted for the largest share. The large share of this segment can be attributed to the recurring cost of services such as software upgrades/updates and maintenance.

“Healthcare providers is the largest end user segment in the healthcare interoperability solutions market in 2020”

Based on end user, the healthcare providers segment is expected to register the highest CAGR during the forecast period. Factors responsible for the growth of this segment are increasing patient volume, the need to curtail the rising healthcare costs, and government mandates.

“APAC to witness the highest growth rate during the forecast period.”

The Asia Pacific market is projected to grow at the highest CAGR during the forecast period. Market growth in the APAC region is mainly driven by factors such as increasing government initiatives for eHealth, rising medical tourism, growing demand for quality healthcare, and the growing need for the implementation and integration of medical devices and HCIT solutions to provide cost-effective and quality care to patients.

Healthcare Interoperability Solutions Market by Region

To know about the assumptions considered for the study, download the pdf brochure

Key Market Players

The products and services market is dominated by a few globally established players such as include Cerner Corporation (US), Epic Systems Corporation (US), Infor, Inc. (US), Koninklijke Philips NV (Netherlands), InterSystems Corporation (US).

Get online access to the report on the World's First Market Intelligence Cloud

  • Easy to Download Historical Data & Forecast Numbers
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
Request Sample

Scope of the Report

Report Metric

Details

Market size available for years

2019–2026

Base year considered

2020

Forecast period

2021–2026

Forecast units

Billion (USD)

Segments covered

Type, level of Interoperability, end user, and region.

Geographies covered

North America, Europe, Asia Pacific, Latin America, and Middle East and Africa

Companies covered

Cerner Corporation (US), Epic Systems Corporation (US), Infor, Inc. (US), Koninklijke Philips NV (Netherlands), InterSystems Corporation (US), Orion Health Group Limited (New Zealand), IBM Watson Health (US), Lyniate (US), Change Healthcare (US), NextGen Healthcare, Inc. (US), and Medical Information Technology, Inc. (US), iNTERFACEWARE (Canada), OSP Labs (US), ViSolve, Inc. (US), Jitterbit (US), Virtusa Corp. (US), and Summit Healthcare Services, Inc. (US), MphRx, Inc (US), Wipro Ltd. (India), eMids Technologies Inc. (US), Nalashaa Healthcare (US), DeeVita LLC (US).

The study categorizes the healthcare interoperability solutions market based on product, type, technology, application, animal type, end user at regional and global level.

Global Healthcare interoperability solutions Market, by Type

  • Introduction
  • Software Solutions
  • Services

Healthcare interoperability solutions Market, By Software Solutions

  • Introduction
  • EHR interoperability solutions
  • Lab system interoperability solutions
  • Imaging system interoperability solutions
  • Healthcare information exchange interoperability solutions
  • Enterprise interoperability solutions
  • Other healthcare interoperability solutions.

Healthcare interoperability solutions Market, By Level of Interoperability

  • Introduction
  • Foundational Interoperability
  • Structural Interoperability
  • Semantic Interoperability

Healthcare interoperability solutions Market, By End User

  • Introduction
  • Healthcare Providers
  • Healthcare Payers
  • Pharmacies

Healthcare interoperability solutions Market, By Healthcare Providers

  • Introduction
  • Hospitals & Clinics
  • Long-term Care centers
  • Diagnostics & Imaging centers
  • Other Healthcare Providers

Global Healthcare interoperability solutions Market, by Region

  • North America
    • US
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Netherlands
    • Rest Of Europe
  • Asia Pacific
    • Japan
    • Australia
    • Rest of APAC
  • Latin America
  • Middle East & Africa

Recent Developments

  • In May 2021, Epic Systems (US) partnered with Anthem, Inc. (US) to ease administrative burdens and address potential gaps in care by harnessing Epic’s Payer Platform, which will be embedded directly into Anthem’s Health OS.
  • In May 2021, InterSystems Corporation (US) partnered with Oncodesign (France). Under this partnership, Oncodesign will use the InterSystems’ IRIS for Health solution to organize and leverage healthcare data to accelerate the search for new treatments in oncology using AI.
  • In January 2021, Koninklijke Philips (Netherlands) signed an agreement to acquire Capsule Technologies, Inc. (US) to transform the delivery of care along the health continuum with integrated solutions.
  • In February 2019, Veradigm (US) entered into a partnership with NextGen Healthcare, Inc. (US) to improve connectivity and data exchange with payers & labs.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 29)
    1.1 OBJECTIVES OF THE STUDY
    1.2 MARKET DEFINITION
           1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY
           1.2.2 MARKETS COVERED
           1.2.3 YEARS CONSIDERED FOR THE STUDY
    1.3 CURRENCY
    1.4 LIMITATIONS
    1.5 STAKEHOLDERS
    1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY (Page No. - 33)
    2.1 RESEARCH APPROACH
          FIGURE 1 RESEARCH DESIGN
           2.1.1 SECONDARY RESEARCH
                    2.1.1.1 Key data from secondary sources
           2.1.2 PRIMARY DATA
                    2.1.2.1 Primary sources
                    2.1.2.2 Key data from primary sources
                    2.1.2.3 Insights from primary experts
                                FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
    2.2 MARKET SIZE ESTIMATION: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET
          FIGURE 3 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
          FIGURE 4 CAGR PROJECTIONS: OVERALL HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET
           2.2.1 TOP-DOWN APPROACH
    2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
          FIGURE 5 DATA TRIANGULATION METHODOLOGY
    2.4 MARKET RANKING ANALYSIS
    2.5 ASSUMPTIONS FOR THE STUDY
    2.6 LIMITATIONS
           2.6.1 METHODOLOGY-RELATED LIMITATIONS
           2.6.2 SCOPE-RELATED LIMITATIONS
    2.7 RISK ASSESSMENT
          TABLE 1 RISK ASSESSMENT: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET

3 EXECUTIVE SUMMARY (Page No. - 45)
    FIGURE 6 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE ,2021 VS. 2026 (USD MILLION)
    FIGURE 7 HEALTHCARE INTEROPERABILITY SOFTWARE SOLUTIONS MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION)
    FIGURE 8 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL, 2021 VS. 2026 (USD MILLION)
    FIGURE 9 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET,  BY END USER, 2021 VS. 2026 (USD MILLION)
    FIGURE 10 GEOGRAPHICAL SNAPSHOT OF THE HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET

4 PREMIUM INSIGHTS (Page No. - 50)
    4.1 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET OVERVIEW
          FIGURE 11 GOVERNMENT INITIATIVES TO ENHANCE PATIENT CARE AND SAFETY—A KEY FACTOR DRIVING MARKET GROWTH
    4.2 ASIA PACIFIC: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE & COUNTRY (2020)
          FIGURE 12 SERVICES SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE APAC HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET IN 2020
    4.3 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
          FIGURE 13 APAC MARKET TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
    4.4 REGIONAL MIX: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET (2021–2026)
          FIGURE 14 NORTH AMERICA TO DOMINATE THE MARKET DURING THE FORECAST PERIOD (2021–2026)
    4.5 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET: DEVELOPED VS. DEVELOPING MARKETS, 2021 VS. 2026
          FIGURE 15 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH BETWEEN 2021 AND 202

5 MARKET OVERVIEW (Page No. - 54)
    5.1 INTRODUCTION
    5.2 MARKET DYNAMICS
          FIGURE 16 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
           5.2.1 DRIVERS
                    5.2.1.1 Growing need to curtail healthcare costs
                    5.2.1.2 Government initiatives to enhance patient care and safety
                    5.2.1.3 Government funding for healthcare interoperability
                    5.2.1.4 Rapid adoption of electronic health records and other healthcare IT solutions
           5.2.2 RESTRAINTS
                    5.2.2.1 Lack of true interoperability solutions
                    5.2.2.2 Lack of standards
                    5.2.2.3 Use of outdated legacy systems
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Emerging markets for healthcare interoperability solutions in developing countries
           5.2.4 CHALLENGES
                    5.2.4.1 Increasing complexity with lack of consistent data
                    5.2.4.2 Shortage of skilled healthcare IT professionals
                    5.2.4.3 Data privacy concerns
    5.3 PATENT ANALYSIS
           5.3.1 PATENT PUBLICATION TRENDS FOR HEALTHCARE INTEROPERABILITY SOLUTIONS
                    FIGURE 18 PATENT PUBLICATION TRENDS (JANUARY 2011–DECEMBER 2021)
           5.3.2 JURISDICTION AND TOP APPLICANT ANALYSIS
                    FIGURE 19 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR HEALTHCARE INTEROPERABILITY SOLUTION PATENTS (JANUARY 2011 TO DECEMBER 2021)
                    FIGURE 20 TOP APPLICANT COUNTRIES/REGIONS FOR HEALTHCARE INTEROPERABILITY SOLUTION PATENTS (JANUARY 2011 TO DECEMBER 2021)
    5.4 ECOSYSTEM ANALYSIS
          FIGURE 21 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET: ECOSYSTEM ANALYSIS
    5.5 TECHNOLOGY ANALYSIS
           5.5.1 MACHINE LEARNING
           5.5.2 SMART ON FHIR
           5.5.3 AI PLATFORMS
    5.6 ADJACENT MARKET ANALYSIS
           5.6.1 HEALTHCARE IT INTEGRATION MARKET
                    FIGURE 22 HEALTHCARE IT INTEGRATION MARKET OVERVIEW
           5.6.2 HEALTHCARE IT MARKET
                    FIGURE 23 HEALTHCARE IT MARKET OVERVIEW

6 INDUSTRY INSIGHTS (Page No. - 69)
    6.1 INTRODUCTION
    6.2 INDUSTRY TRENDS
           6.2.1 FAST HEALTHCARE INTEROPERABILITY RESOURCES
           6.2.2 SMART ON FHIR
           6.2.3 GROWING NEED FOR SEMANTIC INTEROPERABILITY
           6.2.4 INCREASING ADOPTION OF APPLICATION PROGRAMMING INTERFACE
    6.3 INTEROPERABILITY STANDARDS
          TABLE 2 KEY STANDARDS FOR INTEROPERABILITY IN THE DIGITAL HEALTH SPECTRUM
    6.4 IMPACT OF COVID-19 ON THE HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET
    6.5 REGULATORY ANALYSIS
          TABLE 3 KEY REGULATIONS & STANDARDS GOVERNING HEALTHCARE INTEROPERABILITY TECHNOLOGIES GLOBALLY

7 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE (Page No. - 79)
    7.1 INTRODUCTION
          TABLE 4 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE ,2019–2026 (USD MILLION)
    7.2 SOFTWARE SOLUTIONS
          TABLE 5 HEALTHCARE INTEROPERABILITY SOFTWARE SOLUTIONS MARKET ,BY TYPE, 2019–2026(USD MILLION)
          TABLE 6 HEALTHCARE INTEROPERABILITY SOFTWARE SOLUTIONS MARKET ,BY COUNTRY, 2019–2026 (USD MILLION)
           7.2.1 EHR INTEROPERABILITY SOLUTIONS
                    7.2.1.1 Large installation base of EHR systems and the need to make them interoperable—key factors driving market growth
                                TABLE 7 EHR INTEROPERABILITY SOLUTIONS OFFERED BY MAJOR PLAYERS
                                TABLE 8 EHR INTEROPERABILITY SOLUTIONS MARKET, BY COUNTRY ,2019–2026 (USD MILLION)
           7.2.2 LAB SYSTEM INTEROPERABILITY SOLUTIONS
                    7.2.2.1 Increasing cost of operations and decreasing reimbursements for laboratory services to boost the adoption of these solutions
                                TABLE 9 LAB SYSTEM INTEROPERABILITY SOLUTIONS OFFERED BY MAJOR PLAYERS
                                TABLE 10 LAB SYSTEM INTEROPERABILITY SOLUTIONS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
           7.2.3 IMAGING SYSTEM INTEROPERABILITY SOLUTIONS
                    7.2.3.1 Rising need for data interoperability and increasing usage of smart devices to drive market growth
                                TABLE 11 IMAGING SYSTEM INTEROPERABILITY SOLUTIONS OFFERED BY MAJOR PLAYERS
                                TABLE 12 IMAGING SYSTEM INTEROPERABILITY SOLUTIONS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
           7.2.4 HEALTHCARE INFORMATION EXCHANGE INTEROPERABILITY SOLUTIONS
                    7.2.4.1 Large investments by the federal government to drive the adoption of these solutions
                                TABLE 13 HEALTHCARE INFORMATION EXCHANGE INTEROPERABILITY SOLUTIONS OFFERED BY MAJOR PLAYERS
                                TABLE 14 HEALTHCARE INFORMATION EXCHANGE INTEROPERABILITY SOLUTIONS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
           7.2.5 ENTERPRISE INTEROPERABILITY SOLUTIONS
                    7.2.5.1 Advancing software technology and the rising demand for expanded care delivery are driving the growth of this segment
                                TABLE 15 ENTERPRISE INTEROPERABILITY SOLUTIONS OFFERED BY MAJOR PLAYERS
                                TABLE 16 ENTERPRISE INTEROPERABILITY SOLUTIONS MARKET, BY COUNTRY ,2019–2026 (USD MILLION)
           7.2.6 OTHER HEALTHCARE INTEROPERABILITY SOLUTIONS
                    TABLE 17 PRACTICE MANAGEMENT AND MEDICAL BILLING SOFTWARE SOLUTIONS OFFERED BY MAJOR PLAYERS
                    TABLE 18 OTHER HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET ,BY COUNTRY, 2019–2026 (USD MILLION)
    7.3 SERVICES
          TABLE 19 SERVICES OFFERED BY MAJOR PLAYERS
          TABLE 20 HEALTHCARE INTEROPERABILITY SERVICES MARKET, BY COUNTRY ,2019–2026 (USD MILLION)

8 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET ,BY INTEROPERABILITY LEVEL (Page No. - 95)
    8.1 INTRODUCTION
          TABLE 21 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL, 2019–2026 (USD MILLION)
    8.2 FOUNDATIONAL INTEROPERABILITY
           8.2.1 NEED FOR SAFE AND ACCURATE DATA EXCHANGE ACROSS DISPARATE SYSTEMS TO DRIVE MARKET GROWTH
                    TABLE 22 FOUNDATIONAL INTEROPERABILITY SOLUTIONS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
    8.3 STRUCTURAL INTEROPERABILITY
           8.3.1 STRUCTURAL INTEROPERABILITY ENSURES INTERPRETATION OF DATA EXCHANGE BETWEEN SYSTEMS AT THE DATA FIELD LEVEL
                    TABLE 23 STRUCTURAL INTEROPERABILITY SOLUTIONS MARKET, BY COUNTRY ,2019–2026 (USD MILLION)
    8.4 SEMANTIC INTEROPERABILITY
           8.4.1 SEMANTIC INTEROPERABILITY SEGMENT TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD
                    TABLE 24 SEMANTIC INTEROPERABILITY SOLUTIONS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)

9 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER (Page No. - 101)
    9.1 INTRODUCTION
          TABLE 25 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER ,2019–2026 (USD MILLION)
    9.2 HEALTHCARE PROVIDERS
          TABLE 26 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2019–2026 (USD MILLION)
          TABLE 27 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY COUNTRY, 2019–2026 (USD MILLION)
           9.2.1 HOSPITALS & CLINICS
                    9.2.1.1 Increasing patient volume and the rising need to reduce errors in data management to drive market growth
                                TABLE 28 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2019–2026 (USD MILLION)
           9.2.2 LONG-TERM CARE CENTERS
                    9.2.2.1 Increasing number of long-term care centers and the need to maintain compliance with medical reforms to drive market growth
                                TABLE 29 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR LONG-TERM CARE CENTERS, BY COUNTRY, 2019–2026 (USD MILLION)
           9.2.3 DIAGNOSTIC & IMAGING CENTERS
                    9.2.3.1 Increasing volume of clinical data and need to streamline imaging workflows to drive market growth
                                TABLE 30 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR DIAGNOSTIC & IMAGING CENTERS, BY COUNTRY, 2019–2026 (USD MILLION)
           9.2.4 OTHER HEALTHCARE PROVIDERS
                    TABLE 31 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR OTHER HEALTHCARE PROVIDERS, BY COUNTRY, 2019–2026 (USD MILLION)
    9.3 HEALTHCARE PAYERS
           9.3.1 PAYER INTEROPERABILITY HELPS TO DECREASE EMERGENCY DEPARTMENT & HOSPITAL STAYS AND REPEAT TESTS & PROCEDURES
                    TABLE 32 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PAYERS, BY COUNTRY, 2019–2026 (USD MILLION)
    9.4 PHARMACIES
           9.4.1 PHARMACIES USE HIE SOLUTIONS TO PROVIDE INDIVIDUALIZED CARE AND SUPPORT TO PATIENTS
                    TABLE 33 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR PHARMACIES ,BY COUNTRY/REGION, 2019–2026 (USD MILLION)

10 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY REGION (Page No. - 112)
     10.1 INTRODUCTION
             FIGURE 24 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES
             TABLE 34 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY REGION ,2019–2026 (USD MILLION)
             TABLE 35 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY COUNTRY ,2019–2026 (USD MILLION)
     10.2 NORTH AMERICA
             FIGURE 25 NORTH AMERICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET SNAPSHOT
             TABLE 36 NORTH AMERICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET ,BY COUNTRY, 2019–2026 (USD MILLION)
             TABLE 37 NORTH AMERICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET ,BY TYPE, 2019–2026 (USD MILLION)
             TABLE 38 NORTH AMERICA: HEALTHCARE INTEROPERABILITY SOFTWARE SOLUTIONS MARKET, BY TYPE, 2019–2026 (USD MILLION)
             TABLE 39 NORTH AMERICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET ,BY INTEROPERABILITY LEVEL, 2019–2026 (USD MILLION)
             TABLE 40 NORTH AMERICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET ,BY END USER, 2019–2026 (USD MILLION)
             TABLE 41 NORTH AMERICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2019–2026 (USD MILLION)
             10.2.1 US
                        10.2.1.1 Growing need to curtail soaring healthcare costs to drive market growth in the US
                                      TABLE 42 US: KEY MACROINDICATORS
                                      TABLE 43 US: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE ,2019–2026 (USD MILLION)
                                      TABLE 44 US: HEALTHCARE INTEROPERABILITY SOFTWARE SOLUTIONS MARKET ,BY TYPE, 2019–2026 (USD MILLION)
                                      TABLE 45 US: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET ,BY INTEROPERABILITY LEVEL, 2019–2026 (USD MILLION)
                                      TABLE 46 US: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER, 2019–2026 (USD MILLION)
                                      TABLE 47 US: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2019–2026 (USD MILLION)
             10.2.2 CANADA
                        10.2.2.1 Healthcare digitization to support the adoption of healthcare interoperability solutions in Canada
                                      TABLE 48 CANADA: KEY MACROINDICATORS
                                      TABLE 49 CANADA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                      TABLE 50 CANADA: HEALTHCARE INTEROPERABILITY SOFTWARE SOLUTIONS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                      TABLE 51 CANADA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET ,BY INTEROPERABILITY LEVEL, 2019–2026 (USD MILLION)
                                      TABLE 52 CANADA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET,  BY END USER, 2019–2026 (USD MILLION)
                                      TABLE 53 CANADA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2019–2026 (USD MILLION)
     10.3 EUROPE
             FIGURE 26 EUROPE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET SNAPSHOT
             TABLE 54 EUROPE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET ,BY COUNTRY, 2019–2026 (USD MILLION)
             TABLE 55 EUROPE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2019–2026 (USD MILLION)
             TABLE 56 EUROPE: HEALTHCARE INTEROPERABILITY SOFTWARE SOLUTIONS MARKET, BY TYPE, 2019–2026 (USD MILLION)
             TABLE 57 EUROPE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET ,BY INTEROPERABILITY LEVEL, 2019–2026 (USD MILLION)
             TABLE 58 EUROPE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET ,BY END USER, 2019–2026 (USD MILLION)
             TABLE 59 EUROPE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2019–2026 (USD MILLION)
             10.3.1 GERMANY
                        10.3.1.1 Government initiatives to modernize the healthcare system and increasing healthcare expenditure to drive the market growth in Germany
                                      TABLE 60 GERMANY: KEY MACROINDICATORS
                                      TABLE 61 GERMANY: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET ,BY TYPE, 2019–2026 (USD MILLION)
                                      TABLE 62 GERMANY: HEALTHCARE INTEROPERABILITY SOFTWARE SOLUTIONS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                      TABLE 63 GERMANY: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET ,BY INTEROPERABILITY LEVEL, 2019–2026 (USD MILLION)
                                      TABLE 64 GERMANY: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET ,BY END USER, 2019–2026 (USD MILLION)
                                      TABLE 65 GERMANY: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2019–2026 (USD MILLION)
             10.3.2 UK
                        10.3.2.1 Government initiatives to drive the demand for healthcare interoperability solutions in the UK
                                      TABLE 66 UK: KEY MACROINDICATORS
                                      TABLE 67 UK: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE ,2019–2026 (USD MILLION)
                                      TABLE 68 UK: HEALTHCARE INTEROPERABILITY SOFTWARE SOLUTIONS MARKET ,BY TYPE, 2019–2026 (USD MILLION)
                                      TABLE 69 UK: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL, 2019–2026 (USD MILLION)
                                      TABLE 70 UK: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET ,BY END USER, 2019–2026 (USD MILLION)
                                      TABLE 71 UK: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2019–2026 (USD MILLION)
             10.3.3 FRANCE
                        10.3.3.1 Government measures to curtail healthcare expenditures to promote the adoption of healthcare interoperability solutions in France
                                      TABLE 72 FRANCE: KEY MACROINDICATORS
                                      TABLE 73 FRANCE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                      TABLE 74 FRANCE: HEALTHCARE INTEROPERABILITY SOFTWARE SOLUTIONS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                      TABLE 75 FRANCE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET ,BY INTEROPERABILITY LEVEL, 2019–2026 (USD MILLION)
                                      TABLE 76 FRANCE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET ,BY END USER, 2019–2026 (USD MILLION)
                                      TABLE 77 FRANCE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2019–2026 (USD MILLION)
             10.3.4 ITALY
                        10.3.4.1 Government initiatives are driving the healthcare interoperability solutions market in Italy
                                      TABLE 78 ITALY: KEY MACROINDICATORS
                                      TABLE 79 ITALY: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                      TABLE 80 ITALY: HEALTHCARE INTEROPERABILITY SOFTWARE SOLUTIONS MARKET ,BY TYPE, 2019–2026 (USD MILLION)
                                      TABLE 81 ITALY: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL, 2019–2026 (USD MILLION)
                                      TABLE 82 ITALY: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER, 2019–2026 (USD MILLION)
                                      TABLE 83 ITALY: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2019–2026 (USD MILLION)
             10.3.5 NETHERLANDS
                        10.3.5.1 Robust healthcare infrastructure and eHealth initiatives are expected to drive the market in the Netherlands
                                      TABLE 84 NETHERLANDS: KEY MACROINDICATORS
                                      TABLE 85 NETHERLANDS: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET ,BY TYPE, 2019–2026 (USD MILLION)
                                      TABLE 86 NETHERLANDS: HEALTHCARE INTEROPERABILITY SOFTWARE SOLUTIONS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                      TABLE 87 NETHERLANDS: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET ,BY INTEROPERABILITY LEVEL, 2019–2026 (USD MILLION)
                                      TABLE 88 NETHERLANDS: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET ,BY END USER, 2019–2026 (USD MILLION)
                                      TABLE 89 NETHERLANDS: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2019–2026 (USD MILLION)
             10.3.6 REST OF EUROPE
                        TABLE 90 ROE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE ,2019–2026 (USD MILLION)
                        TABLE 91 ROE: HEALTHCARE INTEROPERABILITY SOFTWARE SOLUTIONS MARKET ,BY TYPE, 2019–2026 (USD MILLION)
                        TABLE 92 ROE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET ,BY INTEROPERABILITY LEVEL, 2019–2026 (USD MILLION)
                        TABLE 93 ROE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER, 2019–2026 (USD MILLION)
                        TABLE 94 ROE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2019–2026 (USD MILLION)
     10.4 ASIA PACIFIC
             TABLE 95 ASIA PACIFIC: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET ,BY TYPE, 2019–2026 (USD MILLION)
             TABLE 96 ASIA PACIFIC: HEALTHCARE INTEROPERABILITY SOFTWARE SOLUTIONS MARKET, BY TYPE, 2019–2026 (USD MILLION)
             TABLE 97 ASIA PACIFIC: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET ,BY INTEROPERABILITY LEVEL, 2019–2026 (USD MILLION)
             TABLE 98 ASIA PACIFIC: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET ,BY END USER, 2019–2026 (USD MILLION)
             TABLE 99 ASIA PACIFIC: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2019–2026 (USD MILLION)
             10.4.1 JAPAN
                        10.4.1.1 Japan is the largest healthcare interoperability market in APAC
                                      TABLE 100 JAPAN: KEY MACROINDICATORS
                                      TABLE 101 JAPAN: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                      TABLE 102 JAPAN: HEALTHCARE INTEROPERABILITY SOFTWARE SOLUTIONS MARKET ,BY TYPE, 2019–2026 (USD MILLION)
                                      TABLE 103 JAPAN: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET ,BY INTEROPERABILITY LEVEL, 2019–2026 (USD MILLION)
                                      TABLE 104 JAPAN: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER, 2019–2026 (USD MILLION)
                                      TABLE 105 JAPAN: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2019–2026 (USD MILLION)
             10.4.2 AUSTRALIA
                        10.4.2.1 Growing government initiatives to drive market growth in Australia
                                      TABLE 106 AUSTRALIA: KEY MACROINDICATORS
                                      TABLE 107 AUSTRALIA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET ,BY TYPE, 2019–2026 (USD MILLION)
                                      TABLE 108 AUSTRALIA: HEALTHCARE INTEROPERABILITY SOFTWARE SOLUTIONS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                      TABLE 109 AUSTRALIA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET ,BY INTEROPERABILITY LEVEL, 2019–2026 (USD MILLION)
                                      TABLE 110 AUSTRALIA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET ,BY END USER, 2019–2026 (USD MILLION)
                                      TABLE 111 AUSTRALIA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2019–2026 (USD MILLION)
             10.4.3 REST OF ASIA PACIFIC
                        TABLE 112 ROAPAC: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                        TABLE 113 ROAPAC: HEALTHCARE INTEROPERABILITY SOFTWARE SOLUTIONS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                        TABLE 114 ROAPAC: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET ,BY INTEROPERABILITY LEVEL, 2019–2026 (USD MILLION)
                        TABLE 115 ROAPAC: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET ,BY END USER, 2019–2026 (USD MILLION)
                        TABLE 116 ROAPAC: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2019–2026 (USD MILLION)
     10.5 LATIN AMERICA
             10.5.1 BRAZIL, ARGENTINA, AND MEXICO ARE SOME OF THE EMERGING HEALTHCARE MARKETS IN LATIN AMERICA
                        TABLE 117 LATIN AMERICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET ,BY TYPE, 2019–2026 (USD MILLION)
                        TABLE 118 LATIN AMERICA: HEALTHCARE INTEROPERABILITY SOFTWARE SOLUTIONS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                        TABLE 119 LATIN AMERICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET,  BY INTEROPERABILITY LEVEL, 2019–2026 (USD MILLION)
                        TABLE 120 LATIN AMERICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET,  BY END USER, 2019–2026 (USD MILLION)
                        TABLE 121 LATIN AMERICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2019–2026 (USD MILLION)
     10.6 MIDDLE EAST & AFRICA
             10.6.1 UAE IS EXPECTED TO OFFER GROWTH OPPORTUNITIES FOR THE HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET IN THE REGION
                        TABLE 122 MIDDLE EAST & AFRICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                        TABLE 123 MIDDLE EAST & AFRICA: HEALTHCARE INTEROPERABILITY SOFTWARE SOLUTIONS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                        TABLE 124 MIDDLE EAST & AFRICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL, 2019–2026 (USD MILLION)
                        TABLE 125 MIDDLE EAST & AFRICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER, 2019–2026 (USD MILLION)
                        TABLE 126 MIDDLE EAST & AFRICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2019–2026 (USD MILLION)

11 COMPETITIVE LANDSCAPE (Page No. - 167)
     11.1 OVERVIEW
             FIGURE 27 KEY GROWTH STRATEGIES ADOPTED BY MARKET PLAYERS FROM JANUARY 2018 TO NOVEMBER 2021
     11.2 MARKET SHARE ANALYSIS
             11.2.1 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET
                        TABLE 127 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET SHARE, BY KEY PLAYER, 2020
     11.3 COMPETITIVE LEADERSHIP MAPPING
             11.3.1 STARS
             11.3.2 EMERGING LEADERS
             11.3.3 PERVASIVE PLAYERS
             11.3.4 PARTICIPANTS
                        FIGURE 28 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET: COMPETITIVE LEADERSHIP MAPPING (2020)
     11.4 COMPETITIVE LEADERSHIP MAPPING FOR START-UPS
             11.4.1 PROGRESSIVE COMPANIES
             11.4.2 DYNAMIC COMPANIES
             11.4.3 STARTING BLOCKS
             11.4.4 RESPONSIVE COMPANIES
                        FIGURE 29 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET: COMPETITIVE LEADERSHIP MAPPING FOR START-UPS (2020)
     11.5 COMPETITIVE SCENARIO
             11.5.1 PRODUCT/SERVICE LAUNCHES & APPROVALS
                        TABLE 128 PRODUCT/SERVICE LAUNCHES & APPROVALS, 2018–2021
             11.5.2 DEALS
                        TABLE 129 DEALS (2018–2021)
     11.6 COMPETITIVE BENCHMARKING
            FIGURE 30 FOOTPRINT OF COMPANIES IN THE HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET
            TABLE 130 PRODUCT FOOTPRINT OF COMPANIES (20 COMPANIES)
            TABLE 131 REGIONAL FOOTPRINT OF COMPANIES (20 COMPANIES)

12 COMPANY PROFILES (Page No. - 179)
(Business Overview, Products Offered, Recent Developments, MnM View Right to win, Strategic choices made, Weaknesses and competitive threats) *
     12.1 KEY PLAYERS
             12.1.1 CERNER CORPORATION
                        TABLE 132 CERNER CORPORATION: BUSINESS OVERVIEW
                        FIGURE 31 CERNER CORPORATION: COMPANY SNAPSHOT (2020)
             12.1.2 EPIC SYSTEMS CORPORATION
                        TABLE 133 EPIC SYSTEMS CORPORATION: BUSINESS OVERVIEW
             12.1.3 INFOR, INC.
                        TABLE 134 INFOR, INC.: BUSINESS OVERVIEW
                        FIGURE 32 INFOR, INC.: COMPANY SNAPSHOT (2019)
             12.1.4 INTERSYSTEMS CORPORATION
                        TABLE 135 INTERSYSTEMS CORPORATION: BUSINESS OVERVIEW
             12.1.5 KONINKLIJKE PHILIPS NV
                        TABLE 136 KONINKLIJKE PHILIPS NV: BUSINESS OVERVIEW
                        FIGURE 33 KONINKLIJKE PHILIPS NV: COMPANY SNAPSHOT (2020)
             12.1.6 ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.
                        TABLE 137 ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.: BUSINESS OVERVIEW
                        FIGURE 34 ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.: COMPANY SNAPSHOT (2020)
             12.1.7 COGNIZANT
                        TABLE 138 COGNIZANT: BUSINESS OVERVIEW
                        FIGURE 35 COGNIZANT: COMPANY SNAPSHOT (2020)
             12.1.8 CHANGE HEALTHCARE
                        TABLE 139 CHANGE HEALTHCARE: BUSINESS OVERVIEW
                        FIGURE 36 CHANGE HEALTHCARE: COMPANY SNAPSHOT (2020)
             12.1.9 NEXTGEN HEALTHCARE, INC.
                        TABLE 140 NEXTGEN HEALTHCARE, INC.: BUSINESS OVERVIEW
                        FIGURE 37 NEXTGEN HEALTHCARE, INC.: COMPANY SNAPSHOT (2020)
             12.1.10 IBM WATSON HEALTH
                        TABLE 141 IBM WATSON HEALTH: BUSINESS OVERVIEW
                        FIGURE 38 IBM CORPORATION: COMPANY SNAPSHOT (2020)
             12.1.11 MEDICAL INFORMATION TECHNOLOGY, INC.
                        TABLE 142 MEDICAL INFORMATION TECHNOLOGY, INC.: BUSINESS OVERVIEW
                        FIGURE 39 MEDICAL INFORMATION TECHNOLOGY, INC.: COMPANY SNAPSHOT (2019)
             12.1.12 LYNIATE
                        TABLE 143 LYNIATE: BUSINESS OVERVIEW
             12.1.13 OSP LABS
                        TABLE 144 OSP LABS: BUSINESS OVERVIEW
             12.1.14 ORION HEALTH GROUP LIMITED
                        TABLE 145 ORION HEALTH GROUP LIMITED: BUSINESS OVERVIEW
                        FIGURE 40 ORION HEALTH GROUP LIMITED: COMPANY SNAPSHOT (2020)
             12.1.15 ONYX TECHNOLOGY LLC
                        TABLE 146 ONYX TECHNOLOGY LLC: BUSINESS OVERVIEW
     12.2 OTHER PLAYERS
             12.2.1 VISOLVE INC.
                        TABLE 147 VISOLVE INC.: BUSINESS OVERVIEW
             12.2.2 JITTERBIT
                        TABLE 148 JITTERBIT: BUSINESS OVERVIEW
             12.2.3 INTERFACEWARE INC.
                        TABLE 149 INTERFACEWARE INC.: BUSINESS OVERVIEW
             12.2.4 VIRTUSA CORP.
                        TABLE 150 VIRTUSA CORP.: BUSINESS OVERVIEW
                        FIGURE 41 VIRTUSA CORPORATION: COMPANY SNAPSHOT (2020)
             12.2.5 SUMMIT HEALTHCARE SERVICES, INC.
                        TABLE 151 SUMMIT HEALTHCARE SERVICES, INC.: BUSINESS OVERVIEW
             12.2.6 MPHRX INC.
             12.2.7 WIPRO LTD.
             12.2.8 EMIDS TECHNOLOGIES INC.
             12.2.9 NALASHAA HEALTHCARE
             12.2.10 DEEVITA LLC

*Details on Business Overview, Products Offered, Recent Developments, MnM View, Right to win, Strategic choices made, Weaknesses and competitive threats might not be captured in case of unlisted companies.

13 APPENDIX (Page No. - 226)
     13.1 INSIGHTS FROM INDUSTRY EXPERTS
     13.2 DISCUSSION GUIDE
     13.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
     13.4 AVAILABLE CUSTOMIZATIONS
     13.5 RELATED REPORTS
     13.6 AUTHOR DETAILS

This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.

Secondary Research

This research study involved the use of comprehensive secondary sources; directories and databases such as D&B, Bloomberg Business, and Factiva; and white papers, annual reports, and company house documents. Secondary research was used to identify and collect information for this extensive, technical, market-oriented, and commercial study of the global Healthcare interoperability solutions Market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, technology perspectives, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.

Primary Research

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology and innovation directors, and related key executives from various key companies and organizations operating in the Healthcare interoperability solutions Market. The primary sources from the demand side include key personnel from hospitals, clinics, physicians’ offices, and healthcare providers and payers.

A breakdown of the primary respondents is provided below:

Healthcare Interoperability Solutions Market Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The market size estimates and forecasts provided in this study are derived through a mix of the bottom-up approach (segmental analysis of major segments) and top-down approach (assessment of utilization/adoption/penetration trends, by type, level of Interoperability,  end user, and region).

Data Triangulation

After arriving at the market size, the total Healthcare interoperability solutions Market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments & subsegments, data triangulation, and market breakdown procedures were employed, wherever applicable.

Objectives of the Study

  • To define, describe, and forecast the healthcare interoperability solutions market by type, interoperability level, end user, and region
  • To provide detailed information about the major factors influencing the market growth (drivers, restraints, opportunities, and industry-specific challenges)
  • To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To forecast the size of the market segments in North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa
  • To profile key players and comprehensively analyze their market shares and core competencies in the healthcare interoperability solutions market
  • To track and analyze competitive developments such as partnerships, agreements, and collaborations; mergers & acquisitions; product developments; and geographical expansions in the healthcare interoperability solutions market

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per your company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to 5)

Geographic Analysis

  • Further breakdown of the Rest of Asia Pacific Healthcare interoperability solutions Market into India, China, New Zealand and others
  • Further breakdown of the Rest of Europe Healthcare interoperability solutions Market into the Spain, Belgium, Switzerland and others
  • Further breakdown of the Latin America Healthcare interoperability solutions Market into Argentina, Colombia, Chile, and others
COVID-19

Get in-depth analysis of the COVID-19 impact on the Healthcare Interoperability Solutions Market

Benchmarking the rapid strategy shifts of the Top 100 companies in the Healthcare Interoperability Solutions Market

Request For Special Pricing
Report Code
HIT 6989
Published ON
Jan, 2022
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Healthcare Interoperability Solutions Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2021 MarketsandMarkets Research Private Ltd. All rights reserved